NCT01564277 2018-01-09Rasburicase and Allopurinol in Treating Patients With Hematologic MalignanciesRoswell Park Cancer InstitutePhase 2 Terminated24 enrolled 13 charts
NCT00230178 2010-01-12Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis SyndromeSanofiPhase 3 Completed280 enrolled 10 charts